Engineered microtissues to model the effects of dynamic heterotypic cell signaling on iPSC-derived human hepatocyte maturation
Source abstract
Abstract
In vitro human liver models are indispensable for compound metabolism/toxicity screening, disease modeling, and regenerative medicine. While induced pluripotent stem cell-derived human hepatocyte-like cells (iHeps) mitigate the sourcing limitations with primary human hepatocytes (PHHs), their functional maturity is rate-limiting for application use. During development, immature hepatoblasts interact with different non-parenchymal cell (NPC) types, such as mesenchyme and endothelia, in a spatiotemporal manner to progress through functional maturation. Modeling such interactions in vitro is critical to elucidate the key regulators of iHep maturation. Here, we utilized high-throughput droplet microfluidics to encapsulate iHeps within monodisperse collagen I microgels (Ø ∼ 250 µm), which were coated with NPCs to generate 'microtissues' placed within microwells in multiwell plates. Embryonic fibroblasts and liver sinusoidal endothelial cells (LSECs) induced the highest level of iHep maturation over 4+ weeks of culture compared to adult hepatic stellate cells (myofibroblastic), liver portal fibroblasts, dermal fibroblasts, and human umbilical vein endothelial cells. Combining iHep microtissues in plates with Transwell inserts containing different NPC types enabled the modeling of dynamic heterotypic signaling on iHep maturation; introducing embryonic fibroblast signaling first, followed by LSECs, led to the highest iHep maturation. Unique cytokine secretion profiles were detected across the top-performing microtissue configurations; stromal-derived factor-1 alpha was validated as one factor that enhanced iHep maturation. Lastly, gene expression patterns and regulatory networks showed adult PHH-like maturation in LSEC/iHep microtissues compared to iHep-only microtissues. Overall, microtissues are useful for elucidating the microenvironmental determinants of iHep maturation and for future use in downstream applications. STATEMENT OF SIGNIFICANCE: Induced pluripotent stem cell-derived hepatocyte-like cells (iHeps) hold great promise for drug screening, disease modeling, and regenerative medicine but often exhibit immature phenotypes. We utilized high-throughput droplet microfluidics to generate 3D microtissues containing iHeps and non-parenchymal cell (NPC) types to elucidate the effects of dynamic NPC signaling on iHep maturation. We observed that iHep maturation is significantly enhanced with embryonic fibroblasts and liver sinusoidal endothelial cells (LSEC) compared to adult liver fibroblasts and non-liver endothelia; the LSEC/iHep microtissues showed adult liver-like gene expression signatures. The highest iHep maturation in microtissues was achieved when mesenchymal stimulation was introduced first, followed by LSEC stimulation. Our platform provides a robust framework to elucidate cellular and molecular mediators of iHep maturation and biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Liver physiology and pathology · 3D Printing in Biomedical Research · Pancreatic function and diabetes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Latest impact of engineered human liver platforms on drug development10.1063/5.0051765 ↗
2. Engineered platforms for maturing pluripotent stem cell-derived liver cells for disease modeling10.1016/j.jcmgh.2023.01.013 ↗
3. iPSC-derived hepatocytes as a platform for disease modeling and drug discovery10.3389/fmed.2019.00265 ↗
4. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells10.1002/hep.23354 ↗
5. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol10.1002/hep.24790 ↗
6. Functional maturation of induced pluripotent stem cell hepatocytes in extracellular matrix-A comparative analysis of bioartificial liver microenvironments10.5966/sctm.2015-0235 ↗
7. Vascularized and functional human liver from an iPSC-derived organ bud transplant10.1038/nature12271 ↗
8. Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with endothelial cells10.1038/s41598-019-45514-3 ↗
9. Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro10.1002/hep.27621 ↗
10. Multicellular liver organoids: generation and importance of diverse specialized cellular components10.3390/cells12101429 ↗
11. Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation10.1038/srep16884 ↗
12. 3-D culture and endothelial cells improve maturity of human pluripotent stem cell-derived hepatocytes10.1016/j.actbio.2019.07.047 ↗
13. Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes10.1016/j.stemcr.2022.01.003 ↗
14. Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies10.1016/j.reprotox.2022.05.005 ↗
15. Improvements in maturity and stability of 3D iPSC-derived hepatocyte-like cell cultures10.3390/cells12192368 ↗
16. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids10.1016/j.cmet.2019.05.007 ↗
17. Challenges for the applications of Human pluripotent stem cell-derived liver organoids10.3389/fcell.2021.748576 ↗
18. Self-assembled matrigel-free iPSC-derived liver organoids demonstrate wide-ranging highly differentiated liver functions10.1093/stmcls/sxac090 ↗
19. Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform
20. Organogenesis and development of the liver10.1016/j.devcel.2010.01.011 ↗
21. Regulatory phases of early liver development: paradigms of organogenesis10.1038/nrg837 ↗
22. Improvement of the cell viability of hepatocytes cultured in three-dimensional collagen gels using pump-free perfusion driven by water level difference10.1038/s41598-022-24423-y ↗
23. Microscale collagen and fibroblast interactions enhance primary human hepatocyte functions in three-dimensional models10.3727/105221620X15868728381608 ↗
24. Engineering liver microtissues for disease modeling and regenerative medicine10.1002/adfm.201909553 ↗
25. Identification of small molecules for human hepatocyte expansion and iPS differentiation10.1038/nchembio.1270 ↗
26. BioJupies: automated generation of interactive notebooks for RNA-Seq data analysis in the cloud10.1016/j.cels.2018.10.007 ↗
27. edgeR: a bioconductor package for differential expression analysis of digital gene expression data10.1093/bioinformatics/btp616 ↗
28. Assessment of engineered cells using CellNet and RNA-seq10.1038/nprot.2017.022 ↗
29. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles10.1073/pnas.0506580102 ↗
30. The Molecular Signatures Database (MSigDB) hallmark gene set collection10.1016/j.cels.2015.12.004 ↗
31. Hepatic stellate cells in physiology and pathology10.1113/JP281061 ↗
32. Gene expression profiles during hepatic stellate cell activation in culture and in vivo10.1053/j.gastro.2007.02.033 ↗
33. Microengineered liver tissues for drug testing10.1177/2211068214566939 ↗
34. The portal fibroblast: not just a poor man's stellate cell10.1053/j.gastro.2014.05.001 ↗
35. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome10.1242/dev.052118 ↗
36. CellNet: network biology applied to stem cell engineering10.1016/j.cell.2014.07.020 ↗
37. Prediction of drug clearance and drug-drug interactions in microscale cultures of human hepatocytes10.1124/dmd.115.066027 ↗
38. Cell-laden microfluidic microgels for tissue regeneration10.1039/C6LC01193D ↗
39. One-step synthesis of composite hydrogel capsules to support liver organoid generation from hiPSCs10.1039/D0BM01085E ↗
40. Hydrogel-based strategies for liver tissue engineering10.1021/cbe.4c00079 ↗
41. The liver matrisome - looking beyond collagens
42. Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis10.1016/j.msec.2020.111160 ↗
43. Collagen-rich liver-derived extracellular matrix hydrogels augment survival and function of primary rat liver sinusoidal endothelial cells and hepatocytes
44. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling, and ADME10.1007/s00204-013-1078-5 ↗
45. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation10.1016/j.pharmthera.2012.12.007 ↗
46. Pluripotent stem cell-derived hepatocyte-like cells10.1016/j.biotechadv.2014.01.003 ↗
47. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development10.1039/C7IB00027H ↗
48. Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression10.1039/C6IB00027D ↗
49. Decellularized liver nanofibers enhance and stabilize the long-term functions of primary human hepatocytes in vitro
50. High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype10.1016/j.actbio.2021.11.015 ↗
51. Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling10.1002/hep.20351 ↗
52. T-cadherin modulates hepatocyte functions in vitro10.1096/fj.07-105155 ↗
53. In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease10.1126/scitranslmed.aah5505 ↗
54. Liver sinusoidal endothelial cell: an update10.1055/s-0037-1617455 ↗
55. Microenvironmental regulation of the sinusoidal endothelial cell phenotype in vitro10.1002/hep.23085 ↗
56. Spatiotemporal regulation of liver development by the Wnt/beta-catenin pathway10.1038/s41598-018-20888-y ↗
57. APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development10.1016/j.ydbio.2008.05.526 ↗
58. PDGF receptors and signaling are required for 3D-structure formation and differentiation of human iPSC-derived hepatic spheroids10.3390/ijms24087075 ↗
59. Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat10.1126/science.1244880 ↗
60. IL-33-ST2 axis in liver disease: progression and challenge10.1155/2017/5314213 ↗
61. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment10.3389/fimmu.2022.919973 ↗
62. Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy10.3389/fimmu.2014.00253 ↗
63. Pentraxin-3 and endothelial dysfunction10.1016/bs.acc.2019.03.005 ↗
64. Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss10.1152/ajplung.00171.2022 ↗
65. Induction and maturation of hepatocyte-like cells in vitro: focus on technological advances and challenges10.3389/fcell.2021.765980 ↗
66. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice10.1136/gutjnl-2014-307874 ↗
67. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis10.1038/nature12681 ↗
68. Human induced pluripotent stem cell derived hepatocytes provide insights on parenteral nutrition associated cholestasis in the immature liver10.1038/s41598-021-90510-1 ↗
69. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues10.1097/FPC.0b013e32810f2e58 ↗
70. Hepatocyte polarity10.1002/j.2040-4603.2013.tb00490.x ↗
71. Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration10.1073/pnas.0909374107 ↗
72. In vitro differentiation of pluripotent stem cells into hepatocyte like cells - basic principles and current progress10.1016/j.scr.2022.102763 ↗